MV MANAGEMENT XI L L C
Q4 2021 Form 13-F

MENLO PARK, CALIFORNIA
CIK 0001503556 · CRD 161248 · Exempt reporting adviser
$231.5M Reported Value Total
Exempt Reporting Adviser
Source: Form ADV filed 2026-04-01
Reported value
$231.5M
Quarter over quarter
0.0%
Holdings
4
Top-10 concentration
100.0%

Key People

Named on the latest Form 13-F filing — not necessarily an owner
Venky Ganesan
Managing Member of General Partner

Filing Navigation

13F Metrics

Loading 13F Metrics

Q4 2021 13F record

Q4 2021 13F filing summary

Q4 2021 Form 13F portfolio summary
Period of report December 31, 2021
Filed February 15, 2022
Form 13F-HR
Reported value $231.5M
Positions 4
Change in reported value First reported quarter
Top-10 concentration 100.0%

13F filings by quarter

Form 13F filings by quarter
Quarter Positions Value
Q3 2023 13F
Filed Nov 14, 2023
3 $60.1M
Q2 2023 13F
Filed Jul 24, 2023
3 $57.2M
Q1 2023 13F
Filed May 2, 2023
3 $65.3M
Q4 2022 13F
Filed Jan 31, 2023
3 $57.5M
Q3 2022 13F
Filed Nov 14, 2022
4 $138.0M
Q2 2022 13F
Filed Jul 28, 2022
4 $110.0M
Q1 2022 13F
Filed May 16, 2022
4 $144.0M
Q4 2021 13F
Filed Feb 15, 2022
4 $231.5M

Top 4 holdings · Q4 2021

Largest Q4 2021 13F positions by reported value
# Holding Reported value % of portfolio
1 ROVR ROVER GROUP INC $112.3M 48.52%
2 POSH POSHMARK INC $85.4M 36.88%
3 RXRX RECURSION PHARMACEUTICALS IN $33.8M 14.59%
4 ANGI ANGI INC $17.0K < 0.01%

Values as reported on the Q4 2021 Form 13F. Every position is in the holdings table below.

Filing Details

Loading Activities
Loading Sector Allocation
Crunching numbers

Potential New Buys

Finding Potential New Buys

Holdings

Building table
Loading SEC filing data
Loading Form 4 Filings

Beneficial Ownership (Schedule 13D/13G)

Loading 13D/G filings